Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin for Renal Ischaemia-Reperfusion Injury in Abdominal Aortic Aneurysm Surgery
TCTR20220720006Phase 3Enrolling by invitation
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of melatonin in Kidney ischemia reperfusion injury and abdominal aortic aneurysm (AAA) (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Started Jul 2022; status: enrolling by invitation.
02
Drugs
melatonin
03
Conditions
Kidney ischemia reperfusion injuryabdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on TCTR20220720006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220720006.